From: Selection of Novel Analogs of Thalidomide with Enhanced Tumor Necrosis Factor α Inhibitory Activity
Compound | Amount (mg/kg) | Cytokine Level (ng/ml) | |
---|---|---|---|
TNFα | IL-10 | ||
LPS (5 mg/kg) +: | |||
None (control) | — | 4.5 ± 1.5 | 19.9 ± 5.1 |
Thalidomide | 1 | 2.2 ± 0.7a | 25.6 ± 5.6 |
10 | 2.1 ± 0.8a | 25.3 ± 5.6 | |
100 | 1.7 ± 0.5a | 32.4 ± 4.8a | |
CC-1069 | 1 | 3.1 ± 1.0 | 25.7 ± 2.1 |
10 | 1.5 ± 0.2a | 28.7 ± 4.1a | |
100 | 0.6 ± 0.3a | 44.8 ± 5.6a | |
CC-1104 | 1 | 4.9 ± 0.8 | 13.0 ± 0.3 |
10 | 3.2 ± 0.3 | 16.7 ± 3.8 | |
100 | 1.9 ± 0.4a | 17.9 ± 2.3 | |
CC-1115 | 1 | 2.7 ± 0.9 | 26.6 ± 2.8 |
10 | 2.7 ± 0.4 | 29.9 ± 2.5a | |
100 | 1.6 ± 0.4a | 32.4 ± 2.4a |